Literature DB >> 29966467

Radiation therapy in primary testicular lymphoma: does practice match the standard of care?

Thomas A Ollila1,2, Adam J Olszewski1,2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29966467      PMCID： PMC6318068          DOI： 10.1080/10428194.2018.1480776

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  15 in total

1.  Survival Claims From Observational Data on Cancer Therapy.

Authors:  Adam J Olszewski; Jaleh Falah; Jorge J Castillo
Journal:  J Clin Oncol       Date:  2016-02-16       Impact factor: 44.544

Review 2.  Primary testicular lymphoma.

Authors:  Chan Y Cheah; Andrew Wirth; John F Seymour
Journal:  Blood       Date:  2013-11-26       Impact factor: 22.113

3.  Time to treatment is an independent prognostic factor in aggressive non-Hodgkin lymphomas.

Authors:  Adam J Olszewski; Thomas Ollila; John L Reagan
Journal:  Br J Haematol       Date:  2018-04-24       Impact factor: 6.998

4.  Radiation therapy improves survival in patients with testicular diffuse large B-cell lymphoma<sup/>.

Authors:  Jennifer C Ho; Bouthaina S Dabaja; Sarah A Milgrom; Grace L Smith; Jay P Reddy; Ali Mazloom; Ken H Young; Lijuan Deng; L Jeffrey Medeiros; Wenli Dong; Pamela K Allen; Therese Y Andraos; Nathan H Fowler; Loretta J Nastoupil; Yasuhiro Oki; Luis E Fayad; Francesco Turturro; Sattva S Neelapu; Jason Westin; Fredrick B Hagemeister; Maria Alma Rodriguez; Chelsea C Pinnix
Journal:  Leuk Lymphoma       Date:  2017-05-09

5.  First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial.

Authors:  Umberto Vitolo; Annalisa Chiappella; Andrés J M Ferreri; Maurizio Martelli; Ileana Baldi; Monica Balzarotti; Chiara Bottelli; Annarita Conconi; Henry Gomez; Armando Lopez-Guillermo; Giovanni Martinelli; Francesco Merli; Domenico Novero; Lorella Orsucci; Vincenzo Pavone; Umberto Ricardi; Sergio Storti; Mary K Gospodarowicz; Franco Cavalli; Andreas H Sarris; Emanuele Zucca
Journal:  J Clin Oncol       Date:  2011-06-06       Impact factor: 44.544

Review 6.  Using the National Cancer Database for Outcomes Research: A Review.

Authors:  Daniel J Boffa; Joshua E Rosen; Katherine Mallin; Ashley Loomis; Greer Gay; Bryan Palis; Kathleen Thoburn; Donna Gress; Daniel P McKellar; Lawrence N Shulman; Matthew A Facktor; David P Winchester
Journal:  JAMA Oncol       Date:  2017-12-01       Impact factor: 31.777

7.  Primary testicular diffuse large B-cell lymphoma: a population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of rituximab.

Authors:  Jacob D Gundrum; Michelle A Mathiason; Derek B Moore; Ronald S Go
Journal:  J Clin Oncol       Date:  2009-09-21       Impact factor: 44.544

8.  A non-parametric graphical representation of the relationship between survival and the occurrence of an event: application to responder versus non-responder bias.

Authors:  R Simon; R W Makuch
Journal:  Stat Med       Date:  1984 Jan-Mar       Impact factor: 2.373

9.  Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group.

Authors:  E Zucca; A Conconi; T I Mughal; A H Sarris; J F Seymour; U Vitolo; R Klasa; M Ozsahin; G M Mead; M A Gianni; S Cortelazzo; A J M Ferreri; A Ambrosetti; M Martelli; C Thiéblemont; H Gomez Moreno; G Pinotti; G Martinelli; R Mozzana; S Grisanti; M Provencio; M Balzarotti; F Laveder; G Oltean; V Callea; P Roy; F Cavalli; M K Gospodarowicz
Journal:  J Clin Oncol       Date:  2003-01-01       Impact factor: 44.544

10.  Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era.

Authors:  Li Tao; James M Foran; Christina A Clarke; Scarlett L Gomez; Theresa H M Keegan
Journal:  Blood       Date:  2014-04-04       Impact factor: 25.476
View more
  1 in total

Review 1.  Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.

Authors:  Thomas A Ollila; Adam J Olszewski
Journal:  Curr Treat Options Oncol       Date:  2018-06-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.